A prospective randomized controlled study of iron sucrose injection in patient with cardiac valvular surgery

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800014776

Enrollment

Unknown

Registered

2018-02-04

Start date

2018-03-01

Completion date

Unknown

Last updated

2019-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

valvular heart disease

Interventions

experimental group:Intravenous drip of iron sucrose injection

control group:Intravenous drip of saline solution

Eligibility

Sex/Gender

All

Age

20 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients aged 20-70 years with cardiac valvular surgery and Hb and iron metabolism in accordance with the diagnostic criteria for functional iron deficiency anemia

Exclusion criteria

Exclusion criteria: 1. Patients allergic to iron; 2. Patients with determined iron overload or hereditary iron utilization disorder; 3. Patients with severe hepatic insufficiency.

Design outcomes

Primary

Measure	Time frame
hemoglobin;red blood cell count;	—

Secondary

Measure	Time frame
serum ferritin concentration;serum ferritin concentration;blood transfusion;wound recovery;ICU time;use of antibiotics;mortality;	—

Countries

China

Contacts

Public ContactHansong Sun

Fuwai Hospital, Chinese Academy of Medical Scenices

shs1505@sina.com+86 13701330715

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026